(Q69372214)

English

Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

scientific article published on 01 January 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

author name string

M Fekete

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

J L Wittliff

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

publication date

1 January 1989

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

Journal of Clinical Laboratory Analysis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

137-147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

Cultured mammary carcinoma cells contain gonadotropin-releasing hormone-like immunoreactivity, GnRH binding sites and chorionic gonadotropin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Metabolism of steroid-modifying anticancer agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Presence of somatomedin receptors on primary human breast and colon carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Prostatic epidermal growth factor receptors and their regulation by androgens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Alteration of EGF-receptor binding in human breast cancer cells by antineoplastic agents.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Endocrine therapy of breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Steroid-hormone receptors in breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Characterization of Pituitary Membrane Receptors for Somatostatin in the Rat*

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

The clinical biology of hormone-responsive breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Antitumor Effects of Analogs of Hypothalamic Hormones in Endocrine-Dependent Cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Epidermal growth factor receptors in human breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Gonadotropin-releasing hormone binding sites in human breast carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Radioiodinated Nondegradable Gonadotropin-Releasing Hormone Analogs: New Probes for the Investigation of Pituitary Gonadotropin-Releasing Hormone Receptors*

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

LHRH-Agonist treatment in clinical and experimental human breast cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Treatment of breast cancer with gonadotropin-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1002/JCLA.1860030302

Identifiers

10.1002/JCLA.1860030302

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2569034%20AND%20SRC:MED&resulttype=core&format=json

1 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69372214&oldid=2158966337"